ALS Drugs: FDA May Adjust Development Recommendations In Real Time For Ongoing Programs

 
• By Sue Sutter
  
Real time
Lessons learned from activities under FDA's ALS Science Strategy may be applied in real time to ongoing development programs. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards